S

Shanghai Rendu Biotechnology Co Ltd
SSE:688193

Watchlist Manager
Shanghai Rendu Biotechnology Co Ltd
SSE:688193
Watchlist
Price: 49.55 CNY -1.16% Market Closed
Market Cap: ¥2B

Shanghai Rendu Biotechnology Co Ltd
Investor Relations

Shanghai Rendu Biotechnology Co., Ltd. develops molecular diagnostic tests. The company is headquartered in Shanghai, Shanghai and currently employs 528 full-time employees. The company went IPO on 2022-03-30. The firm utilizes ribonucleic acid (RNA) isothermal amplification technology to provides multiple series of diagnostic reagents, including respiration series, reproduction series, enterovirus series, blood-borne diseases series and other diagnostic reagents. The firm also designs and manufactures medical instruments. The firm mainly sells its products within domestic market.

Show more
Loading
688193
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Ms. Minghui Yu
GM & Director
No Bio Available
Mr. Tingjiang Cai
Accounting Supervisor, CFO & Secretary
No Bio Available
Ms. Ruohua Cao
Deputy GM & Director
No Bio Available
Ms. Zhenling Cui
Senior Director of R&D
No Bio Available
Mr. Feng man Zhou
Deputy Director of Instrumentation
No Bio Available

Contacts

Address
SHANGHAI
Shanghai
No. B, Building 15, No. 528, Ruiqing Road, East District, Zhangjiang Hi-Tech Park
Contacts
+862150720069
www.rdbio.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett